Работы, на которые ссылается эта работа
Работ: 159
Работа: PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén +25
Статья2017Цитирований: 2ABIEfficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean‐Claude Tardif, Simon Kouz, David D. Waters +22
Статья2019Цитирований: 2ABITwo Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend +8
Статья2020Цитирований: 2ABIColchicine in Patients with Chronic Coronary Disease
Stefan M. Nidorf, Aernoud T.L. Fiolet, Arend Mosterd +30
Статья2020Цитирований: 2ABIMolecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)
Rainer Schulz, Klaus‐Dieter Schlüter, Ulrich Laufs
Обзорная статья2015Цитирований: 2ABIFrom junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis
Sonam Dhamija, Sven Diederichs
Обзорная статья2016Цитирований: 2ABILet-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk
Zongwei Lin, Junfeng Ge, Zhe Wang +6
Статья2017Цитирований: 2ABIPCSK9 induces a pro-inflammatory response in macrophages
Chiara Ricci, Massimiliano Ruscica, Marina Camera +10
Статья2018Цитирований: 2ABIRole of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Paolo Raggi, Jacques Genest, Jon T. Giles +4
Обзорная статья2018Цитирований: 2ABIPCSK9 and inflammation: a review of experimental and clinical evidence
Amir Abbas Momtazi‐Borojeni, Sarvenaz Sabouri-Rad, Antonio M. Gotto +5
Обзорная статья2019Цитирований: 2ABIThe role of long noncoding RNA in major human disease
Xiaoli Zhang, Ruiyun Hong, Weiqiang Chen +2
Обзорная статья2019Цитирований: 2ABIProprotein Convertase Subtilisin/Kexin Type 9
Chiara Macchi, Nicola Ferri, Cesare R. Sirtori +3
Обзорная статья2021Цитирований: 2ABITargeting inflammation in atherosclerosis — from experimental insights to the clinic
Обзорная статья2021Цитирований: 2ABIHow the immune system shapes atherosclerosis: roles of innate and adaptive immunity
Payel Roy, Marco Orecchioni, Klaus Ley
Обзорная статья2021Цитирований: 2ABIPCSK9-targeted therapies: present and future approaches
Mahmoud Al Rifai, Christie M. Ballantyne
Обзорная статья2021Цитирований: 2ABIInflammation and atherosclerosis: signaling pathways and therapeutic intervention
Peng Kong, Ziyang Cui, Xiao-Fu Huang +3
Обзорная статья2022Цитирований: 2ABI